Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo

Bibliographic Details
Title: Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo
Authors: Weiran Li, MD, Jinping Gao, MD, He Huang, MD, Tingting Zhu, MD, Xianfa Tang, MD, Ruochen Zhang, MM, Xiaojian Chen, MM, Yang Wang, BS, Yaohua Zhang, MD, PhD, Xuejun Zhang, MD, PhD, Yong Cui, MD, PhD, Youwen Zhou, MD, PhD, Bo Zhang, MD, PhD
Source: JAAD Int
JAAD International, Vol 22, Iss, Pp 16-19 (2025)
Publisher Information: Elsevier BV, 2025.
Publication Year: 2025
Subject Terms: JAK inhibitor, ruxolitinib, RL1-803, efficacy, Research Letter, progressive, Dermatology, nonsegmental vitiligo, combination therapy
Document Type: Article
Other literature type
Language: English
ISSN: 2666-3287
DOI: 10.1016/j.jdin.2025.04.014
Access URL: https://doaj.org/article/8c6cef192dd148daa56b30c429272290
Rights: CC BY
Accession Number: edsair.doi.dedup.....d53627a6bc5d8fa40986f6df411b183a
Database: OpenAIRE
Description
ISSN:26663287
DOI:10.1016/j.jdin.2025.04.014